These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27871833)

  • 41. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.
    Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C
    Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
    Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
    J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
    Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles.
    Hashim Ali K; Mohsin Ansari M; Ali Shah F; Ud Din F; Abdul Basit M; Kim JK; Zeb A
    J Microencapsul; 2019 Jan; 36(1):10-20. PubMed ID: 30719944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design:
    Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA
    Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.
    Jadhav NV; Vavia PR
    AAPS PharmSciTech; 2017 Oct; 18(7):2764-2773. PubMed ID: 28353172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mung bean (Vigna radiata) porous starch for solubility and dissolution enhancement of poorly soluble drug by solid dispersion.
    Nadaf S; Jadhav A; Killedar S
    Int J Biol Macromol; 2021 Jan; 167():345-357. PubMed ID: 33253744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant.
    Christoforidou T; Giasafaki D; Andriotis EG; Bouropoulos N; Theodoroula NF; Vizirianakis IS; Steriotis T; Charalambopoulou G; Fatouros DG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods.
    Dadej A; Woźniak-Braszak A; Bilski P; Piotrowska-Kempisty H; Józkowiak M; Pawełczyk A; Dadej D; Łażewska D; Jelińska A
    Eur J Pharm Sci; 2022 Apr; 171():106133. PubMed ID: 35066153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
    Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
    Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Drug Release Model Constructed by Factorial Design to Investigate the Interaction Between Host Mesoporous Silica Carriers and Drug Molecules.
    Liu T; Wang K; Jiang M; Wan L
    AAPS PharmSciTech; 2019 Feb; 20(3):126. PubMed ID: 30809738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of particle design on oral absorption of poorly water-soluble drug in a silica particle-supercritical fluid system.
    Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
    Chem Pharm Bull (Tokyo); 2011; 59(6):686-91. PubMed ID: 21628901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidant properties of probucol released from mesoporous silica.
    Lau M; Giri K; Garcia-Bennett AE
    Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
    Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.